FourThought Financial’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

FourThought Financial’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-963	Closed	-$32K	–	1600
2021 Q3	$32K	Buy	963 +10	+1%	+$319	﹤0.01%	832
2021 Q2	$34K	Sell	953 -16	-2%	-$619	﹤0.01%	821
2021 Q1	$43K	Sell	969 -72	-7%	-$3.35K	0.01%	726
2020 Q4	$59K	Buy	+1,041	New	+$61.7K	0.01%	626

Other funds holding DCPH

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

FourThought Financial's DCPH Position: Q4 2021 in Review

FourThought Financial sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q4 2021, closing a stake of 963 shares — an estimated $32K sold.

FourThought Financial first reported a position in DCPH in Q4 2020 and held it in 4 quarters. The position peaked at $59K in Q4 2020. 140 funds tracked by Wall St. Rank hold DCPH as of Q4 2021.

FourThought Financial reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
FourThought Financial sold 963 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2021, an estimated $32K.
FourThought Financial first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2020 and held it in 4 quarters.
FourThought Financial's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $59K in Q4 2020.
140 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2021.

Based on FourThought Financial's 13F filing for Q4 2021, filed 14 Jan 2022.